Evidence map›Paper›PMID 36763098›Full record

ReviewCurrent gastroenterology reports2023

Food as Medicine: How to Influence the Microbiome and Improve Symptoms in Patients with Irritable Bowel Syndrome.

Shyam Vedantam, Erica Graff, Nabiha Shabbir Khakoo, Nidah Shabbir Khakoo, Michelle Pearlman

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current gastroenterology reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shyam VedantamDepartment of Medicine, University of Miami, Miami, FL, USA.ORCID http://orcid.org/0000-0002-4088-0095
Erica GraffDepartment of Medicine, University of Miami, Miami, FL, USA.ORCID http://orcid.org/0000-0003-3584-0619
Nabiha Shabbir KhakooDepartment of Medicine, University of Miami, Miami, FL, USA.ORCID http://orcid.org/0000-0003-2242-6267
Nidah Shabbir KhakooDivision of Digestive Diseases, Emory University, Atlanta, GA, USA.ORCID http://orcid.org/0000-0003-2561-3826
Michelle PearlmanDivision of Digestive Health and Liver Diseases, Department of Medicine, University of Miami, Miami, FL, USA. m.pearlman@med.miami.edu.ORCID http://orcid.org/0000-0001-6231-3705

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThis review highlights effects of dietary interventions on the gut microbiome and gastrointestinal symptoms in those with irritable bowel syndrome (IBS). RECENT

findingsIt is hypothesized that gut dysbiosis factors into the pathophysiology of IBS. Various diets that influence the microbiome and intestinal physiology may have therapeutic properties. At present, data suggests that implementation of personalized dietary interventions have a mixed, but overall positive effect on the gut microbiome and IBS symptoms. The effect of dietary modification on the gut microbiome and GI symptoms in patients with IBS is a topic that has garnered interest due to the increasing prevalence of IBS and heightened awareness of the importance of gut health. The composition of the gut microbiome may be modulated by promoting fiber intake and implementation of exclusionary diets and dietary supplements; however, additional studies are needed to provide evidence-based guidelines in this patient population.

Indexed as

Gastrointestinal MicrobiomeIrritable Bowel SyndromeDietHumansFiberGlutenGut microbiomeIrritable bowel syndromeLow FODMAPProbiotic

Identifiers

PMID36763098

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.